Compare Hims and Hers Health Inc (HIMS) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs STMicroelectronics NV — how do they compare? Hims and Hers Health Inc trades at $32.91 (market cap $7.57B), while STMicroelectronics NV trades at $64.81 (market cap $55.80B). The key difference: STMicroelectronics NV is far larger — about 7.4× Hims and Hers Health Inc's market cap, and STMicroelectronics NV pays a 0.58% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | STM | |
|---|---|---|
Market Cap | $7.57B | $55.80B |
Sector | Health | Financials |
52-Week High | $66.18 | $79.91 |
52-Week Low | $14.52 | $21.20 |
Enterprise Value | $7.95B | $54.01B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
STM trades at $61.57, down 0.79% with a bearish technical signal. The stock shows mixed fundamentals with a high P/E of 387.88 but strong analyst support (51.72% buy rating). Recent earnings have been inconsistent with two misses in the last three quarters, though Q3 2025 beat expectations. The company maintains solid cash flow generation of $555M in 2025 and is expanding AI partnerships with AWS and NVIDIA to drive future growth.
STM presents a cautious opportunity with 15% upside to the $72.33 consensus target, supported by AI expansion but tempered by declining revenue and thin 1.19% net margins. Key risks include execution on AI initiatives and semiconductor market volatility. The current price near support at $60 offers potential entry but requires monitoring of Q2 earnings due soon.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
